Court Opinion

ID: 812835
Source: CourtListenerOpinion
Date Created: 2012-11-29 20:15:50+00
Date Added: 2024-06-11T13:01:21.157199
License: Public Domain

Case: 12-1523     Document: 59   Page: 1      Filed: 11/29/2012

          NOTE: This order is nonprecedential.

   Wniteb $>tateg {!Court of ~peaIg
       for tbe jfeberaI qcircuit

     THE RESEARCH FOUNDATION OF STATE
          UNIVERSITY OF NEW YORK,
                  Plaintiff,

                           AND
                NEW YORK UNIVERSITY,
                 Plaintiff-Cross Appellant,

                           AND
        GALDERMA LABORATORIES INC.
      AND GALDERMA LABORATORIES, L.P.,
            Plaintiffs-Cross Appellants,

                            v.
         MYLAN PHARMACEUTICALS INC.,
               Defendant-Appellant.

         MYLAN PHARMACEUTICALS INC.,
                Plaintiff-Appellant,

                            v.
       GALDERMA LABORATORIES INC. AND
        GALDERMA LABORATORIES, L.P.,
           Defendants-Cross Appellants,

                           AND
Case: 12-1523     Document: 59   Page: 2      Filed: 11/29/2012

RESEARCH FOUNDATION V. MYLAN PHARMACEUTICALS               2

      SUPERNUS PHARMACEUTICALS, INC.,
              Defendant-Appellee.

          2012-1523, -1524, -1555, -1556, -1557

   Appeals from the United States District Court for the
District of Delaware in case nos. 09-CV-0184 and 10-CV-
0892, Judge Leonard P. Stark.

     THE RESEARCH FOUNDATION OF STATE
          UNIVERSITY OF NEW YORK,
                  Plaintiff,

                           AND
      SUPERNUS PHARMACEUTICALS, INC.,
               Plaintiff-Appellee,

                           AND

                NEW YORK UNIVERSITY,
                 Plaintiff-Cross Appellant,

                           AND

       GALDERMA LABORATORIES INC. AND
        GALDERMA LABORATORIES, L.P.,
            Plaintiffs-Cross Appellants,

                            v.
           IMPAX LABORATORIES, INC.,
               Defendant-Appellant.

          2012-1545, -1546, -1590, -1591, -1592
Case: 12-1523    Document: 59   Page: 3   Filed: 11/29/2012

RESEARCH FOUNDATION V. MYLAN PHARMACEUTICALS          3

   Appeals from the United States District Court for the
District of Delaware in case nos. 09-CV-0703 and 11-CV-
0477, Judge Leonard P. Stark.

       GALDERMA LABORATORIES INC. AND
        GALDERMA LABORATORIES, L.P.,
            Plaintiffs-Cross Appellants,

                          AND

      SUPERNUS PHARMACEUTICALS, INC.,
               Plaintiff-Appellee,

                           v.
 LUPIN LIMITED AND LUPIN PHARMACEUTICALS,
                    INC.,
             Defendants-Appellants.

                    2012-1566, -1596

   Appeals from the United States District Court for the
District of Delaware in case no. 10-CV-1112, Judge Leo-
nard P. Stark.

     THE RESEARCH FOUNDATION OF STATE
          UNIVERSITY OF NEW YORK,
                  Plaintiff,

                         AND
                NEW YORK UNIVERSITY,
                   Plaintiff-Appellant,
Case: 12-1523     Document: 59     Page: 4    Filed: 11/29/2012

RESEARCH FOUNDATION V. MYLAN PHARMACEUTICALS                 4

                            AND

       GALDERMA LABORATORIES INC. AND
        GALDERMA LABORATORIES, L.P.,
              Plaintiffs-Appellants,

                              v.
 LUPIN LIMITED AND LUPIN PHARMACEUTICALS,
                      INC.,
           Defendants-Cross Appellants.

                  2012-1597, -1598, -1599

   Appeals from the United States District Court for the
District of Delaware in case no. 09-CV-0483, Judge Leo-
nard P. Stark.

                       ON MOTION

                         ORDER
     The parties jointly move for an extension of time, un-
til November 20, 2012, for Galderma/Supernus and NYU
to file their response briefs, for an extension of time, until
January 11, 2013, for Mylan, Impax, and Lupin to file
their response/reply briefs, and for an extension of time
until January 28,2013, for Galderma/Supernus and NYU
to file their reply briefs.

    Upon consideration thereof,

    IT Is ORDERED THAT:
Case: 12-1523   Document: 59   Page: 5   Filed: 11/29/2012

RESEARCH FOUNDATION V. MYLAN PHARMACEUTICALS         5

    The motion is granted.

                                FOR THE COURT

                                 /s/ Jan Horbaly
                                Jan Horbaly
                                Clerk
    s27